FLUMIST Receives Approval for Self-Administration in the US
WILMINGTON, Del.-- FLUMIST has made a significant breakthrough as the first influenza vaccine approved for self-administration in the US. This innovative nasal spray, which requires no needles, is designed for adults up to 49 years old. For children between the ages of 2 and 17, parents or caregivers can assist with the administration. This approval from the US Food and Drug Administration (FDA) followed an extensive joint study confirming that individuals 18 and older can safely self-administer or provide the vaccine to eligible younger individuals.
The Importance of FLUMIST’s Approval
Dr. Ravi Jhaveri, a well-respected expert in infectious diseases, highlighted the significance of this approval, stating that families and caregivers can now conveniently protect themselves from influenza at home, without the use of needles. Influenza poses considerable challenges each year, impacting communities, healthcare systems, and individuals alike. This new vaccination option emphasizes the importance of increased access and addresses healthcare disparities.
Improving Accessibility and Convenience
Iskra Reic, AstraZeneca’s Executive Vice President, noted that this approval is a crucial step toward overcoming healthcare access barriers. For more than twenty years, FLUMIST has been the only licensed nasal spray flu vaccine in the US, and now it enables individuals and families to get vaccinated outside of traditional healthcare settings easily.
The Impact of Seasonal Influenza
Seasonal influenza results in approximately 1 billion infections each year, with between 3 and 5 million people suffering severe cases that require medical attention. Beyond health issues, influenza can severely disrupt daily life; it is responsible for around 47% of missed school days and causes 1 to 2 lost workdays each year. Vaccination rates have notably declined since the COVID-19 pandemic's onset, which underscores the urgent need for easily accessible vaccination options.
Home Delivery for FLUMIST
Thanks to FLUMIST Home, individuals aged 18 and over can now have the vaccine delivered straight to their doorstep. The process is simple: individuals fill out a questionnaire that a pharmacist reviews before shipping the vaccine. Traditional healthcare facilities will still provide FLUMIST for those preferring professional administration.
Key Safety Information for FLUMIST Users
It’s crucial to keep certain safety considerations in mind before using FLUMIST. Individuals with severe egg allergies or a history of serious adverse reactions to vaccines should avoid FLUMIST. For children aged 2 to 17, it’s essential to consult a healthcare provider, especially if they take aspirin or have a history of wheezing. After vaccination, common side effects may include a runny nose, sore throat, or mild fever.
Understanding FLUMIST
FLUMIST is the only live attenuated influenza vaccine (LAIV) available in nasal spray form. Recommended by the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Pediatrics, it has been instrumental in influenza prevention since its approval in 2003, with nearly 200 million doses administered around the world. AstraZeneca is committed to ongoing enhancements and innovations in vaccine delivery, as shown by recent usability studies indicating that self-administering FLUMIST is both effective and safe.
AstraZeneca: Leaders in Biopharmaceuticals
AstraZeneca is a top global biopharmaceutical company focused on scientific innovation, aimed at discovering, developing, and commercializing new medications in fields like Oncology and Rare Diseases, among others. With a major presence in over 125 countries, AstraZeneca's pioneering medicines are making a substantial difference in global health.
Frequently Asked Questions
1. What is FLUMIST?
FLUMIST is a live attenuated influenza vaccine provided through a nasal spray, approved for children, adolescents, and adults aged 2 to 49.
2. Who can self-administer FLUMIST?
Adults aged 18 to 49 can self-administer FLUMIST, and parents and caregivers are allowed to administer it to children aged 2 to 17.
3. What are the common side effects of FLUMIST?
The usual side effects include a runny or stuffy nose, sore throat, and a mild fever above 100°F.
4. How can I receive FLUMIST at home?
Individuals aged 18 and older can complete a questionnaire to qualify for home delivery of FLUMIST through the FLUMIST Home service.
5. What are the safety considerations for using FLUMIST?
People with severe egg allergies, previous severe reactions to vaccines, or specific health conditions should consult their healthcare provider before using FLUMIST.
